← back to search

Mylin A. Torres

Emory Healthcare · US
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Cancer survivorship and care, and Breast Implant and Reconstruction.
h-index
32
citations
3,552
works
187
NIH funding
primary concept
email

Recent publications

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy
New England Journal of Medicine 2025cited by 72position: middledoi
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Clinical Insights
JCO Oncology Practice 2025cited by 4position: lastdoi
Abstract GS02-07: Loco-Regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node-negative After Neoadjuvant Chemotherapy: Primary Outcomes of NRG Oncology/NSABP B-51/RTOG 1304
Cancer Research 2024cited by 63position: middledoi
Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis
BMJ 2024cited by 25position: middledoi
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates
Nature Communications 2024cited by 12position: middledoi
Redlining−associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome
Frontiers in Oncology 2023cited by 22position: middledoi
DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases
Nature Communications 2022cited by 132position: middledoi
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer
npj Breast Cancer 2022cited by 114position: middledoi
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2022cited by 34position: middledoi
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review
CA A Cancer Journal for Clinicians 2022cited by 34position: middledoi
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management
Endocrinology 2022cited by 26position: middledoi
Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities
Breast Cancer Research and Treatment 2022cited by 18position: middledoi
Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
International Journal of Molecular Sciences 2022cited by 15position: middledoi
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2− metastatic breast cancer in US real-world clinical practice
Breast Cancer Research 2021cited by 124position: middledoi
Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta
Journal of the National Comprehensive Cancer Network 2021cited by 13position: middledoi
Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status
PLoS ONE 2020cited by 27position: middledoi
Automatic Breast Cancer Cohort Detection from Social Media for Studying Factors Affecting Patient-Centered Outcomes
Lecture notes in computer science 2020cited by 13position: middledoi
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
Breast Cancer Research and Treatment 2020cited by 10position: middledoi
Disadvantaged neighborhoods and racial disparity in breast cancer outcomes: the biological link
Cancer Causes & Control 2019cited by 86position: middledoi
NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).
Journal of Clinical Oncology 2019cited by 72position: middledoi
Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia
npj Breast Cancer 2019cited by 32position: middledoi
Time to Radiation After Oncoplastic Reduction
Annals of Plastic Surgery 2018cited by 37position: middledoi
CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
International Journal of Breast Cancer 2018cited by 25position: middledoi
Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial
Cancer 2017cited by 80position: middledoi
Comparison of different cell type correction methods for genome-scale epigenetics studies
BMC Bioinformatics 2017cited by 79position: middledoi
Depressive symptoms and inflammation are independent risk factors of fatigue in breast cancer survivors
Psychological Medicine 2017cited by 63position: lastdoi
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Breast Cancer Research and Treatment 2016cited by 539position: middledoi
ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA
Cell Reports 2016cited by 66position: middledoi
A prospective study of quality of life in breast cancer patients undergoing radiation therapy
Advances in Radiation Oncology 2016cited by 50position: lastdoi
Benefit of adjuvant radiotherapy after breast‐conserving therapy among elderly women with T1‐T2N0 estrogen receptor‐negative breast cancer
Cancer 2016cited by 29position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Donna Mister · Emory University8 papers (2012–2018)Lauren E. McCullough · American Cancer Society7 papers (2019–2023)Andrew H. Miller · Albert Einstein College of Medicine6 papers (2013–2017)Keerthi Gogineni · Emory University6 papers (2019–2023)Jennifer C. Felger · Emory University5 papers (2013–2017)Karen N. Conneely · Emory University4 papers (2014–2023)Jasmine M. Miller‐Kleinhenz · State Street (United States)4 papers (2020–2023)Jeffrey M. Switchenko · Emory University4 papers (2013–2021)Kevin C. Ward · Emory University4 papers (2016–2021)Sheryl Gabram‐Mendola · Emory University4 papers (2012–2023)Olivia D’Angelo · Boston University3 papers (2020–2023)Lindsay J. Collin · Intermountain Healthcare3 papers (2019–2023)Walter J. Curran · Piedmont Atlanta Hospital3 papers (2013–2019)Uma Krishnamurti · Yale New Haven Hospital3 papers (2020–2023)Renjian Jiang · Emory University3 papers (2016–2021)Albert Losken · Emory University3 papers (2012–2018) · 3 papers (2014–2022)Angela DeMichele · Brigham and Women's Hospital2 papers (2021–2022)Susan A. McCloskey · University of California, Los Angeles2 papers (2014–2019)Toncred M. Styblo · Emory University2 papers (2012–2018)